4.1 Article

Superagonistic Fluorinated Vitamin D3 Analogs Stabilize Helix 12 of the Vitamin D Receptor

Journal

CHEMISTRY & BIOLOGY
Volume 15, Issue 10, Pages 1029-1034

Publisher

CELL PRESS
DOI: 10.1016/j.chembiol.2008.08.008

Keywords

-

Funding

  1. Fonds voor Wetenschappelijk Onderzoek (FWO) [G-0508.05, G.0553.06]
  2. NucSys (EU Marie Curie RTN)
  3. Ministeno de Educacion y Ciencia [SAF2007-60341]
  4. Ministerio de Sanidad y Consumo of Spain [RD06/0020/0009]
  5. European Commission [QLG2-CT-220-0098, LSHG-CT-2006-031220]
  6. CNRS
  7. INSERM
  8. ULP
  9. RTICC [RD06/0020/0009]

Ask authors/readers for more resources

Side chain fluorination is often used to make analogs of 1,25-dihydroxyvitamin D-3 [1,25(OH)(2)D-3] resistant to degradation by 24-hydroxylase. The fluorinated nonsteroidal analogs CD578, WU515, and WY1113 have an increased prodifferentiating action on SW480-ADH colon cancer cells, which correlated with stronger induction of vitamin D receptor (VDR)-coactivator interactions and stronger repression of beta-catenin/TCF activity. Cocrystallization of analog CD578 with the zebrafish (z)VDR and an SRC-1 coactivator peptide showed that the fluorine atoms of CD578 make additional contacts with Va1444 and Phe448 of activation helix 12 (H12) of the zVDR and with Leu440 of the H11-H12 loop. Consequently, the SRC-1 peptide makes more contacts with the VDR-CD578 complex than with the VDR-1,25(OH)(2)D-3 Complex. These data show that fluorination not only affects degradation of an analog but can also have direct effects on H12 stabilization.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available